Wang Yang

Title: Wang Yang: Innovator in Modified Immune Cell Therapy

Introduction

Wang Yang is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of modified immune cells. With a total of 2 patents, his work is paving the way for advancements in immunotherapy.

Latest Patents

Wang Yang's latest patents focus on a method for using a four-plasmid system to prepare modified immune effector cells. The method involves forming a lentivirus using four plasmids within 293T cells, extracting the lentivirus, and then transfecting immune effector cells with it. This process enables the expression of a chimeric antigen receptor. Additionally, the patent outlines the use of the immune effector cells obtained through this method and the composition containing these cells.

Career Highlights

Wang Yang is currently associated with Juventas Cell Therapy Ltd., where he continues to innovate in the field of cell therapy. His work is instrumental in developing new therapeutic approaches that harness the power of the immune system.

Collaborations

Wang collaborates with notable colleagues, including Yun Liu and Lin Shi, who contribute to his research and development efforts. Their combined expertise enhances the potential for breakthroughs in modified immune cell therapies.

Conclusion

Wang Yang's innovative work in the field of modified immune cells represents a significant advancement in biotechnology. His patents and collaborations are set to impact the future of immunotherapy positively.